Christine L. Hann
Agency for Science, Technology and Research(SG)Johns Hopkins University(US)National University of Singapore(SG)Johns Hopkins Medicine(US)Sidney Kimmel Comprehensive Cancer Center(US)University of Baltimore(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Cancer therapeutics and mechanisms
Most-Cited Works
- → Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma(2009)1,108 cited
- → Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449(2009)1,011 cited
- → Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma(2009)841 cited
- → Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors(2011)582 cited
- → Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors(2011)546 cited
- → Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer(2012)545 cited